Glenmark Pharmaceuticals

Glenmark Pharmaceuticals is one of the companies to have an enormous growth rate in the Indian Pharmaceutical sector in the present scenario.

The company is ranked 23rd in the domestic sector. The activities of Glenmark Pharmaceuticals are diverse but the main area of the focus of the company lies in the manufacturing of active pharmaceutical ingredient. This segment serves as an intermediary to many of the pharmaceutical companies. Glenmark Pharmaceuticals started its business with the products in the dermatology segment and then followed by respiratory products. Glenmark Pharmaceuticals is one of the pioneers in India in the segment of combination and new molecule therapies.

The company has commercial activities in over 65 countries, which include countries across Latin America, Africa, Asia, and CIS countries.


The values followed at the Glenmark Pharmaceuticals:

• To achieve results
• To respect all
• To gain knowledge through experience

The management body of Glenmark Pharmaceuticals:

• Mr. Gracias Saldanha, Chairman & Non Executive Director
• Mr. Glenn Saldanha, Managing Director & CEO
• Mrs. Cheryl Pinto, Director, Corporate Affairs
• Mr. R. V. Desai, Director, Finance & Legal
• Mr. Abhinna Sundar Mohanty, Director, Formulations
• Mr. Sridhar Gorthi, Non Executive Director
• Mr. Natvarlal B. Desai, Non Executive Director
• Mrs B. E .Saldanha, Non Executive Director
• Mr. Julio F. Ribeiro, Non Executive Director
• Mr. M. Gopal Krishnan, Non Executive Director

Scientific advisory board of Glenmark Pharmaceuticals:

• Prof. Jonathan Robert Sanders Arch
• Dr. Arpad Szallasi
• Prof. Clive P. Page
• Dr. Daniel Drucker
• Prof. Anthony Dayan

The different divisions of Glenmark Pharmaceuticals:

• Glenmark Pharmaceuticals
• Gracewell
• Healtheon
• Milieus
• Integrace
• Majesta
• Zoltan

Some of the modern scientific equipments used by the Glenmark Pharmaceuticals:

• Liquid chromatography and mass spectrometer
• Gas chromatography
• Fluid bed dryer-GLATT
• HPLCs equipped with a variety of detection systems
• X-ray Diffractometer, FTIR, Elemental Analyzer and DSC
• Formulation equipment for lab-scale development
• Nuclear Magnetic Resonance Spectrometer (NMR)
• Other routine analytical equipment

The partners of the Glenmark Pharmaceuticals:

Forest Laboratories, Inc.
Teijin Pharma Limited
Merck KGaA